
Journal of International Oncology ›› 2023, Vol. 50 ›› Issue (7): 425-431.doi: 10.3760/cma.j.cn371439-20230315-00082
• Original Articles • Previous Articles Next Articles
					
													Zhao Qianwen, Peng Danli, Qin Tao, Mao Guofei, Tang Hui, Yang Jun(
)
												  
						
						
						
					
				
Received:2023-03-15
															
							
																	Revised:2023-06-04
															
							
															
							
																	Online:2023-07-08
															
							
																	Published:2023-08-03
															
						Contact:
								Yang Jun,Email: Zhao Qianwen, Peng Danli, Qin Tao, Mao Guofei, Tang Hui, Yang Jun. Analysis of global cancer incidence and mortality from 1990 to 2019[J]. Journal of International Oncology, 2023, 50(7): 425-431.
"
| 地区 | 年份 | 发病例数(万) | 发病率(1/10万) | 标化发病率(1/10万) | 死亡例数(万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 
|---|---|---|---|---|---|---|---|
| 全球 | 1990 | 1 029.59 | 192.45 | 259.54 | 573.26 | 107.16 | 147.23 | 
| 2019 | 2 356.85 | 304.60 | 290.49 | 1 002.28 | 129.54 | 124.66 | |
| 亚洲 | 1990 | 366.61 | 114.88 | 171.75 | 276.03 | 86.50 | 137.71 | 
| 2019 | 937.74 | 205.90 | 197.62 | 557.63 | 122.44 | 120.65 | |
| 欧洲 | 1990 | 300.57 | 373.45 | 298.98 | 172.13 | 213.87 | 168.71 | 
| 2019 | 471.43 | 555.15 | 328.49 | 216.83 | 255.34 | 139.96 | |
| 美洲 | 1990 | 322.79 | 450.89 | 526.31 | 94.06 | 131.39 | 154.11 | 
| 2019 | 853.44 | 844.71 | 672.51 | 160.60 | 158.96 | 126.18 | |
| 非洲 | 1990 | 38.37 | 60.82 | 116.78 | 30.25 | 47.96 | 101.27 | 
| 2019 | 91.70 | 69.72 | 131.54 | 65.89 | 50.10 | 105.24 | |
| 大洋洲 | 1990 | 0.45 | 70.80 | 131.42 | 0.34 | 53.39 | 113.62 | 
| 2019 | 1.21 | 91.77 | 149.70 | 0.87 | 65.83 | 122.70 | 
"
| 顺位 | 男女合计 | 男性 | 女性 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 癌种 | 发病率 (1/10万)  |  标化发病率 (1/10万)  |  癌种 | 发病率 (1/10万)  |  标化发病率 (1/10万)  |  癌种 | 发病率 (1/10万)  |  标化发病率 (1/10万)  | |||
| 1 | 肺癌 | 29.21 | 27.66 | 肺癌 | 39.24 | 40.44 | 乳腺癌 | 51.27 | 45.86 | ||
| 2 | 结直肠癌 | 28.00 | 26.71 | 前列腺癌 | 36.34 | 38.63 | 结直肠癌 | 24.02 | 21.22 | ||
| 3 | 乳腺癌 | 25.88 | 24.17 | 结直肠癌 | 31.94 | 33.06 | 肺癌 | 19.12 | 16.84 | ||
| 4 | 前列腺癌 | 18.23 | 17.39 | 胃癌 | 21.82 | 22.39 | 宫颈癌 | 14.66 | 13.35 | ||
| 5 | 胃癌 | 16.41 | 15.59 | 膀胱癌 | 10.51 | 11.28 | 子宫内膜癌 | 11.28 | 9.99 | ||
| 6 | 白血病 | 8.32 | 8.22 | 食管癌 | 10.02 | 10.13 | 胃癌 | 10.97 | 9.71 | ||
| 7 | 宫颈癌 | 7.31 | 6.81 | 肝癌 | 9.70 | 9.71 | 卵巢癌 | 7.63 | 6.87 | ||
| 8 | 食管癌 | 6.91 | 6.51 | 白血病 | 9.03 | 9.42 | 白血病 | 7.60 | 7.23 | ||
| 9 | 肝癌 | 6.91 | 6.51 | 胰腺癌 | 7.21 | 7.49 | 胰腺癌 | 6.49 | 5.71 | ||
| 10 | 胰腺癌 | 6.85 | 6.57 | 非霍基金淋巴瘤 | 6.86 | 7.20 | 非霍奇金淋巴瘤 | 4.95 | 4.45 | ||
"
| 顺位 | 男女合计 | 男性 | 女性 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 癌种 | 死亡率 (1/10万)  |  标化死亡率 (1/10万)  |  癌种 | 死亡率 (1/10万)  |  标化死亡率 (1/10万)  |  癌种 | 死亡率 (1/10万)  |  标化死亡率 (1/10万)  | |||
| 1 | 肺癌 | 26.40 | 25.18 | 肺癌 | 35.72 | 37.38 | 乳腺癌 | 17.85 | 15.88 | ||
| 2 | 结直肠癌 | 14.03 | 13.69 | 胃癌 | 15.76 | 16.59 | 肺癌 | 17.02 | 14.99 | ||
| 3 | 胃癌 | 12.37 | 11.88 | 结直肠癌 | 15.31 | 16.64 | 结直肠癌 | 12.75 | 11.24 | ||
| 4 | 乳腺癌 | 9.06 | 8.62 | 前列腺癌 | 12.54 | 15.28 | 胃癌 | 8.96 | 7.92 | ||
| 5 | 胰腺癌 | 6.86 | 6.62 | 食管癌 | 9.42 | 9.68 | 宫颈癌 | 7.27 | 6.51 | ||
| 6 | 食管癌 | 6.44 | 6.11 | 肝癌 | 8.60 | 8.73 | 胰腺癌 | 6.56 | 5.77 | ||
| 7 | 前列腺癌 | 6.29 | 6.32 | 胰腺癌 | 7.17 | 7.55 | 卵巢癌 | 5.14 | 4.56 | ||
| 8 | 肝癌 | 6.26 | 5.95 | 白血病 | 4.86 | 5.20 | 肝癌 | 3.91 | 3.46 | ||
| 9 | 白血病 | 4.32 | 4.26 | 膀胱癌 | 4.36 | 5.09 | 白血病 | 3.79 | 3.50 | ||
| 10 | 宫颈癌 | 3.62 | 3.40 | 非霍奇金淋巴瘤 | 3.75 | 3.97 | 食管癌 | 3.44 | 3.02 | ||
| [1] |  
											 Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide[J]. Cancer, 2021, 127(16): 3029-3030. DOI: 10.1002/cncr.33587. 
																							 doi: 10.1002/cncr.33587 pmid: 34086348  | 
										
| [2] |  
											 Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. DOI: 10.1002/ijc.31937. 
																							 doi: 10.1002/ijc.31937 pmid: 30350310  | 
										
| [3] |  
											 Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2018, 4(11): 1553-1568. DOI: 10.1001/jamaoncol.2018.2706. 
																							 doi: 10.1001/jamaoncol.2018.2706 pmid: 29860482  | 
										
| [4] |  
											 Jin G, Zou M, Zhang Y, et al. Time trends, associations and global burden of intraocular foreign bodies[J]. Br J Ophthalmol, 2022, 106(3): 435-439. DOI: 10.1136/bjophthalmol-2020-317063. 
																							 doi: 10.1136/bjophthalmol-2020-317063  | 
										
| [5] |  
											GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204-1222. DOI: 10.1016/S0140-6736(20)30925-9. 
																							 doi: 10.1016/S0140-6736(20)30925-9 pmid: 33069326  | 
										
| [6] |  
											 Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351. DOI: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z. 
																							 doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z pmid: 10649300  | 
										
| [7] |  
											 孙惠昕, 张茂祥, 王婉莹, 等. 癌症筛查与早诊早治的研究进展[J]. 现代肿瘤医学, 2021, 29(18): 3287-3290. DOI: 10.3969/j.issn.1672-4992.2021.18.033. 
																							 doi: 10.3969/j.issn.1672-4992.2021.18.033  | 
										
| [8] |  
											 De Vuyst H, Alemany L, Lacey C, et al. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa[J]. Vaccine, 2013, 31 Suppl 5(5): F32-F46. DOI: 10.1016/j.vaccine.2012.07.092. 
																							 doi: 10.1016/j.vaccine.2012.07.092  | 
										
| [9] |  
											 Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review[J]. Eur J Cancer Care (Engl), 2017, 26(1): e12444. DOI: 10.1111/ecc.12444. 
																							 doi: 10.1111/ecc.12444  | 
										
| [10] |  
											 Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer[J]. Ann Glob Health, 2019, 85(1): 8. DOI: 10.5334/aogh.2419. 
																							 doi: 10.5334/aogh.2419  | 
										
| [11] |  
											 Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control[J]. J Natl Cancer Inst, 2008, 100(23): 1672-1694. DOI: 10.1093/jnci/djn389. 
																							 doi: 10.1093/jnci/djn389 pmid: 19033571  | 
										
| [12] |  
											 de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force[J]. Ann Intern Med, 2014, 160(5): 311-320. DOI: 10.7326/M13-2316. 
																							 doi: 10.7326/M13-2316 pmid: 24379002  | 
										
| [13] |  
											 Buszewski B, Ligor T, Jezierski T, et al. Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines[J]. Anal Bioanal Chem, 2012, 404(1): 141-146. DOI: 10.1007/s00216-012-6102-8. 
																							 doi: 10.1007/s00216-012-6102-8 pmid: 22660158  | 
										
| [14] |  
											 Joko-Fru WY, Miranda-Filho A, Soerjomataram I, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study[J]. Int J Cancer, 2020, 146(5): 1208-1218. DOI: 10.1002/ijc.32406. 
																							 doi: 10.1002/ijc.32406 pmid: 31087650  | 
										
| [15] |  
											 Heath AK, Muller DC, van den Brandt PA, et al. Nutrient-wide association study of 92 foods and nutrients and breast cancer risk[J]. Breast Cancer Research, 2020, 22(1): 5. DOI: 10.1186/s13058-019-1244-7. 
																							 doi: 10.1186/s13058-019-1244-7 pmid: 31931881  | 
										
| [16] |  
											 Thakur P, Seam RK, Gupta MK, et al. Breast cancer risk factor evaluation in a Western Himalayan state: a case-control study and comparison with the Western World[J]. South Asian J Cancer, 2017, 6(3): 106-109. DOI: 10.4103/sajc.sajc_157_16. 
																							 doi: 10.4103/sajc.sajc_157_16 pmid: 28975116  | 
										
| [17] |  
											 Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(12): 713-732. DOI: 10.1038/s41575-019-0189-8. 
																							 doi: 10.1038/s41575-019-0189-8 pmid: 31455888  | 
										
| [18] |  
											 Mohan G, Chattopadhyay S. Cost-effectiveness of leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening: a systematic review[J]. JAMA Oncol, 2020, 6(9): 1434-1444. DOI: 10.1001/jamaoncol.2020.1460. 
																							 doi: 10.1001/jamaoncol.2020.1460  | 
										
| [1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. | 
| [2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. | 
| [3] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. | 
| [4] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. | 
| [5] | Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353. | 
| [6] | Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358. | 
| [7] | Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363. | 
| [8] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. | 
| [9] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. | 
| [10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. | 
| [11] | Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273. | 
| [12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. | 
| [13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. | 
| [14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. | 
| [15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297. | 
| Viewed | ||||||
| 
										Full text | 
									
										 | 
								|||||
| 
										Abstract | 
									
										 | 
								|||||